I’ve always felt that if we could somehow be packaged up with BENE then we would be a much more attractive proposition. Whether that means Bene taking us out or a very large pharma taking both of us I’m not sure. But to your post, the science appears unquestionable and requires no more spruiking…the dollars are all that matter as you say.
as far as updates from PAR, it’s without question the most poorly communicated stock that I’ve ever held..and I’ve held some disappointments in the past.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $112.9M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 31.0¢ | 28.5¢ | $431.5K | 1.469M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 21578 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 9000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |